Join WhatsApp Community

Reduction in Polypharmacy Burden Among Type 2 Diabetes Mellitus Patients Through Comprehensive Diabetes Care Plan-Based Integrative Management: Implications for Adverse Drug Interaction Risk and Health System Cost

Polypharmacy — conventionally defined as the concurrent use of five or more medications — is prevalent among patients with Type 2 Diabetes Mellitus (T2DM) and is associated with adverse drug interactions, treatment non-adherence, and escalating healthcare costs. Integrative management programmes combining Panchakarma-based therapies, structured dietary intervention, and allopathic co-management have shown promise in glycaemic control, yet their impact on medication burden has not been systematically characterised.

  • Dr Rohit Sane Board of directors

    M.D. & CEO

    Dr. Rohit Rane, Founder of Vaidya Sane Ayurved Lab Ltd, pioneers Ayurvedic cardiac care, integrating modern medicine and holistic therapies for heart failure and diabetes.

Disclaimer: The content on this website is for informational purposes only and should not be considered a substitute for medical advice. Please consult a qualified Madhavbaug Ayurvedic doctor before starting any treatment.

Share:

More Posts